• Triazole ALDH2 Activators for Myocardial Ischemia

  2026-09-21

  A 2025 ACS Medicinal Chemistry Letters study used molecular simulation and structural optimization to identify triazole-based ALDH2 activators with improved activity and water solubility. Lead compound Z17 produced the strongest reported ALDH2 activation in the study and improved cardiac function, infarct burden, and injury biomarkers in a mouse ischemia–reperfusion model.

• Trypsin-Responsive Nanomedicine for Acute Pancreatitis

  2026-09-20

  This ACS Nano study introduces a mesoporous organosilica nanomedicine that combines pancreatic acinar cell targeting with trypsin-triggered release of the calcium chelator BAPTA-AM. In a mouse model of acute pancreatitis, the formulation reduced intracellular calcium overload, suppressed inflammatory and necrotic signaling, improved pancreatic biomarkers, and increased survival, while remaining a preclinical platform requiring further translational validation.

• 5-hme-dCTP for 5hmC Assay Design

  2026-09-19

  Learn how 5-hme-dCTP supports calibrated 5hmC assay development without being mistaken for a direct endogenous 5hmC detector. This guide connects nucleotide chemistry, polymerase behavior, and rice drought-response epigenetics to better experimental decisions.

• Bestatin (Ubenimex): Workflows for Protease Research

  2026-09-18

  Bestatin (Ubenimex) provides a selective way to connect aminopeptidase activity with MDR, apoptosis, and inflammatory cell-death phenotypes. This practical guide covers stock preparation, dose selection, assay controls, reference-study translation, and troubleshooting for reproducible experiments.

• PDHA1 Succinylation in Cholangiocarcinoma Immune Escape

  2026-09-18

  A 2025 Nature Communications study identifies PDHA1 K83 succinylation as a metabolic control point linking cholangiocarcinoma metabolism to macrophage immune suppression. The work shows that α-ketoglutarate accumulation activates macrophage OXGR1–MAPK signaling, reduces MHC-II antigen presentation, and that inhibiting succinylation with CPI-613 can improve gemcitabine–cisplatin activity in preclinical models.

• Bestatin (Ubenimex) Experimental Workflows

  2026-09-17

  Bestatin (Ubenimex) combines selective aminopeptidase inhibition with a useful chemical-genetics phenotype in plant jasmonate signaling. This guide translates that evidence into practical workflows for aminopeptidase activity measurement, multidrug resistance (MDR) research, apoptosis assay design, and Arabidopsis screening.

• Minocycline HCl in Retinal Microglia Workflows

  2026-09-17

  Minocycline HCl provides a practical pharmacological perturbation for testing whether microglial activity contributes to retinal amyloid clearance. This guide translates 40-Hz flicker findings into controlled preparation, dosing, endpoint selection, and troubleshooting strategies for inflammation and neuroprotection studies.

• Bay 11-7821: NF-κB Assay Workflow Guide

  2026-09-16

  Bay 11-7821, also called BAY 11-7082, provides a practical downstream perturbation point for separating NF-κB-dependent inflammation from lactate-driven macrophage responses. This workflow guide covers dose finding, reporter and protein readouts, exosomal HMGB1 experiments, apoptosis applications, and troubleshooting of solubility and cytotoxicity artifacts.

• EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag): Assay Design

  2026-09-16

  EZ Cap™ Mouse CD80 mRNA (m1Ψ, HA tag) enables a controlled way to study mouse CD80-mediated T-cell co-stimulation. This guide translates published tumor-vaccine findings into practical assay design, controls, readouts, and interpretation strategies.

• Necrostatin-1 and RIP1: A Translational Lens

  2026-09-15

  A mechanism-first guide to using Necrostatin-1 as a RIP1 kinase inhibitor in necroptosis assays and translational injury models, with a strategic framework connecting microbial virulence, Crohn’s disease biology, and host-cell death without overstating the evidence.

• CCCP as a Functional Stress Test for Mitochondria

  2026-09-15

  CCCP, or carbonyl cyanide m-chlorophenyl hydrazine, is more than an oxidative phosphorylation uncoupler. This article explains how controlled mitochondrial proton gradient disruption can strengthen live-cell morphology assays and improve interpretation of urine-derived stem cell biomarker research.

• HLTP1 and JNK Signaling in Liver Ischemia-Reperfusion

  2026-09-14

  This study identifies human liver transplantation peptide 1 (HLTP1) through peptidomic analysis of clinical liver-transplant samples and reports protection against hepatic ischemia-reperfusion injury (HIRI). Mouse and AML12-cell experiments connect the benefit to suppression of Jun N-terminal kinase (JNK) phosphorylation and reduced hepatocyte apoptosis, providing a mechanistic basis for further peptide development.

• Octyl-α-ketoglutarate for Reliable Cell Assays

  2026-09-14

  Learn how Octyl-α-ketoglutarate, SKU C4321, can help distinguish metabolic changes from true loss of cell viability in HIF and IDH-focused experiments. This scenario-based guide covers assay design, solvent controls, protocol handling, interpretation, and practical product selection.

• Phalloidin (B7678): F-Actin Workflow Guide

  2026-09-13

  Phalloidin (B7678) is a cyclic heptapeptide toxin that binds filamentous actin and supports actin filament stabilization for microscopy and cell-free assays. It is suited to fixed or permeabilized samples, but not to live-cell imaging or experiments requiring reversible actin dynamics.

• Tailored CAR Macrophages for Peritoneal Metastasis

  2026-09-12

  Gu and colleagues developed a macrophage-targeted mRNA lipid nanoparticle platform for programming CAR macrophages directly in the peritoneal cavity. Their comparison of 36 CAR designs identified a CD3ζ–TLR4 intracellular configuration that promoted adaptive immune activation, remodeled the tumor microenvironment, and improved responses to PD-1/L1 blockade.

7939 records 1/530 page Next 12345 下5页 Last page